Clinicopathological comparison between PTCL ‐TBX21 and PTCL‐GATA3 in Japanese patients

ConclusionThe classification of PTCL-NOS into PTCL-TBX21 and PTCL-GATA3 is useful for predicting the prognosis of Japanese patients and stratifying the administration of tumor immune checkpoint inhibitors in clinical practice.

Source: Cancer Medicine - January 18, 2024 Category: Cancer & Oncology Authors: Yasumasa Shimasaki, Hiroaki Miyoshi, Keisuke Kawamoto, Noriaki Yoshida, Tatsuzo Mishina, Kazutaka Nakashima, Teppei Imamoto, Takeshi Sugio, Eriko Yanagida, Takeharu Kato, Kyohei Yamada, Mai Takeuchi, Takaharu Suzuki, Mayuko Moritsubo, Takuya Tags: RESEARCH ARTICLE Source Type: research